Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Non-cash Items (2019 - 2022)

C4 Therapeutics has reported Non-cash Items over the past 4 years, most recently at $1.7 million for Q1 2022.

  • For Q1 2022, Non-cash Items rose 214.0% year-over-year to $1.7 million; the TTM value through Mar 2022 reached $1.7 million, up 214.0%, while the annual FY2021 figure was $1.4 million, 98.67% down from the prior year.
  • Non-cash Items for Q1 2022 was $1.7 million at C4 Therapeutics, up from $1.4 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $102.6 million in Q4 2020 and troughed at $365732.0 in Q3 2020.
  • A 4-year average of $14.2 million and a median of $1.2 million in 2021 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: surged 2037.78% in 2020 and later plummeted 98.67% in 2021.
  • Year by year, Non-cash Items stood at $4.8 million in 2019, then surged by 2037.78% to $102.6 million in 2020, then plummeted by 98.67% to $1.4 million in 2021, then rose by 22.43% to $1.7 million in 2022.
  • Business Quant data shows Non-cash Items for CCCC at $1.7 million in Q1 2022, $1.4 million in Q4 2021, and $1.1 million in Q3 2021.